Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Z4349 is an opioid analgesic drug developed in the 1990s by the pharmaceutical company Zambon. It is a derivative of an older drug viminol, which has been modified to improve potency and metabolic stability. In tests on mice it was found to be several hundred times the potency of morphine.
The analysis highlights Companies, Synthesis and Overview as prominent areas in the source structure around Z4349.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Z4349 shows recurring relationship patterns in the source. For example, Z4349 → Alkylation, Catalytic, Chlorobenzyl, Displacement, Elimination, Esterification, Glutamic, L-glutamic, L-Pyroglutamic, L-Pyroglutaminol, Lactam, N-oxide, Oxidation, Oxo-2-pyrrolidineacetonitrile, Oxopyrrolidin-2-yl, PC13306712, PC56976994, PC6347588, PC88496451, Rosenmund Another extracted example is Z4349 → Interactive image. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
5s group led presence drug potency -5- amino -1- pyrrolidin-2-one acid ester treatment methyl synthesis 2r -butan-2-yl 2-chlorobenzyl opioid zambon
TTTA extracted 31 structured relationships around Z4349. Examples in this analysis include Z4349 → 3D model (JSmol) → Interactive image and Z4349 → CAS Number → 127093-63-4. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Z4349 | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Z4349 | CAS Number | 127093-63-4 | 1.00 | infobox |
| Z4349 | ChemSpider | 8493143 | 1.00 | infobox |
| Z4349 | Formula | C21H33ClN2O2 | 1.00 | infobox |
| Z4349 | Molar mass | 380.96 g·mol−1 | 1.00 | infobox |
| Z4349 | PubChem CID | 10317679 | 1.00 | infobox |
| Z4349 | UNII | TZU6N9X9YS | 1.00 | infobox |
| Z4349 | is a | opioid analgesic drug developed in the 1990s by the pharmaceutical company Zambon | 0.90 | text |
| Z4349 | related to Synthesis | Esterification | 0.60 | section |
| Z4349 | related to Synthesis | L-glutamic | 0.60 | section |
| Z4349 | related to Synthesis | Glutamic | 0.60 | section |
| Z4349 | related to Synthesis | Lactam | 0.60 | section |
The concept neighborhoods around Z4349 bring nearby vocabulary together. In this analysis, examples include -butan-2-yl, 2r and Synthesis. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Z4349, one of the stronger structural bridges in this analysis connects Z4349 with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Z4349 to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Companies, Synthesis & Overview, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Z4349 · EN edition · Analysis: TopicsToTalkAbout